Björn Sjöstrand

Björn Sjöstrand

Born 1968.

Chairman of the Board since 2021

Björn Sjöstrand is CEO and co-founder of Scandinavian Biopharma and has extensive experience from the Life Science industry from leading positions in both Swedish and international companies. Former CEO of UniTech Pharma AB (2010-2011), CEO of Swiss Berna Biotech AG (2006- 2009) a Swiss company specializing in the development and distribution of virus and bacterial vaccines, and CEO of SBLvaccin in Sweden (2001- 2006) a Swedish vaccine company that has successfully developed and launched Dukoral®, a travel vaccine, and CBO and global head of the vaccine division at Crucell (2006 -2009), a Dutch formerly listed company with facilities in the Netherlands, Switzerland and the United States specializing in vaccines and biological drugs. Björn has also been an advisor to the Bill & Melinda Gates Foundation.

Training

Bsc in Ecomomics and Business Administration with Accounting, Örebro Universitet

Other missions

Chairman of the Board of Intervacc AB
Board member of companies within the Scandinavian Biopharma Holding AB Group
Board member of Sjöstrand BioBusiness AB and B&M Sjöstrand AB

Number of shares (as of september 20th,  2021)

441 177

Independent in relation to the Company, its senior executives, and major shareholders